Published in J Pain Manag on January 01, 2008
Current management of sickle cell anemia. Cold Spring Harb Perspect Med (2013) 0.87
Adolescent pediatric pain tool for multidimensional measurement of pain in children and adolescents. Pain Manag Nurs (2013) 0.87
Pain assessment using the adolescent pediatric pain tool: a systematic review. Pain Res Manag (2014) 0.78
Remote monitoring of pain and symptoms using wireless technology in children and adolescents with sickle cell disease. J Am Assoc Nurse Pract (2012) 0.77
Pain in sickle cell disease. Rates and risk factors. N Engl J Med (1991) 9.75
Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol (2005) 1.77
Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool. J Pain Symptom Manage (2002) 1.27
Pain location: validity and reliability of body outline markings by hospitalized children and adolescents. Res Nurs Health (1989) 1.15
A shift from demerol (meperidine) to dilaudid (hydromorphone) improves pain control and decreases admissions for patients in sickle cell crisis. J Emerg Nurs (2004) 1.09
Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease. Pain (2003) 1.09
Management of vaso-occlusive pain in children with sickle cell disease. J Pediatr Hematol Oncol (2003) 1.04
Assessment of postoperation pain in children and adolescents using the adolescent pediatric pain tool. Nurs Res (1993) 1.04
Measuring pain quality: validity and reliability of children's and adolescents' pain language. Pain (1990) 0.91
Management of vasoocclusive pain events in sickle cell disease. Pediatr Emerg Care (2007) 0.85
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol (2007) 1.77
Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease. Pediatr Blood Cancer (2008) 1.62
Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. J Clin Oncol (2006) 1.60
Decision making in pediatric oncology: who should take the lead? The decisional priority in pediatric oncology model. J Clin Oncol (2006) 1.57
Outcomes for children with gallbladder abnormalities and sickle cell disease. J Pediatr (2004) 1.52
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial. Am J Hematol (2013) 1.49
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood (2005) 1.37
Healthcare utilization and expenditures for low income children with sickle cell disease. Pediatr Blood Cancer (2009) 1.28
Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital. Pediatr Blood Cancer (2008) 1.07
A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: opportunities to improve healthcare quality. Pediatr Blood Cancer (2008) 1.04
Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer (2009) 1.02
Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. Oncol Nurs Forum (2007) 1.01
Clinical field testing of an enhanced-activity intervention in hospitalized children with cancer. J Pain Symptom Manage (2007) 0.99
Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort. Blood (2012) 0.98
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood (2013) 0.98
High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer (2011) 0.95
Oxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy. J Pediatr Hematol Oncol (2010) 0.94
Pain experience of children with sickle cell disease who had prolonged hospitalizations for acute painful episodes. Pain Med (2008) 0.92
Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia. Biol Res Nurs (2005) 0.92
Methotrexate-induced alterations in beta-oxidation correlate with cognitive abilities in children with acute lymphoblastic leukemia. Biol Res Nurs (2008) 0.91
Validity and reliability of a new instrument to measure cancer-related fatigue in adolescents. J Pain Symptom Manage (2007) 0.89
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial. Acta Haematol (2008) 0.88
Psychometric and clinical assessment of the 13-item reduced version of the fatigue scale-adolescent instrument. J Pediatr Oncol Nurs (2011) 0.88
Variations in pain, sleep, and activity during hospitalization in children with cancer. J Pediatr Oncol Nurs (2007) 0.88
Intensity, location, and quality of pain in Spanish-speaking children with cancer. Pediatr Nurs (2008) 0.87
Analgesic Response to Morphine in Children with Sickle Cell Disease: A Pilot Study. J Pain Manag (2008) 0.87
Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL. Eur J Cancer (2010) 0.87
Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia. Magn Reson Imaging (2010) 0.87
Sense of humor, childhood cancer stressors, and outcomes of psychosocial adjustment, immune function, and infection. J Pediatr Oncol Nurs (2004) 0.86
The medical home experience among children with sickle cell disease. Pediatr Blood Cancer (2012) 0.86
Increased pulmonary artery pressures among adolescents with sickle cell disease. J Pediatr Hematol Oncol (2005) 0.85
Psychometric and clinical assessment of the 10-item reduced version of the Fatigue Scale-Child instrument. J Pain Symptom Manage (2010) 0.85
Translating scientific advances to improved outcomes for children with sickle cell disease: a timely opportunity. Pediatr Blood Cancer (2011) 0.84
Online exclusive: functional integration of nursing research into a pediatric oncology cooperative group: finding common ground. Oncol Nurs Forum (2003) 0.83
Growth patterns and gastrointestinal symptoms in pediatric patients after hematopoietic stem cell transplantation. Oncol Nurs Forum (2008) 0.82
The meaning of adolescents' eating experiences during bone marrow transplant recovery. J Pediatr Oncol Nurs (2010) 0.82
Oral iron chelation and the treatment of iron overload in a pediatric hematology center. Pediatr Blood Cancer (2009) 0.81
Thromboelastographic and hemostatic characteristics in pediatric patients with sickle cell disease. Arch Pathol Lab Med (2005) 0.81
Reducing central venous catheter-related bloodstream infections in children with cancer. Oncol Nurs Forum (2009) 0.80
Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities. Am J Hematol (2012) 0.80
Shorter hospitalization trends among children with sickle cell disease. Pediatr Blood Cancer (2012) 0.80
Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease. Pediatr Blood Cancer (2011) 0.79
Respiratory symptoms and acute painful episodes in sickle cell disease. J Pediatr Oncol Nurs (2009) 0.79
Association of care in a medical home and health care utilization among children with sickle cell disease. J Natl Med Assoc (2013) 0.79
Trends in blood transfusion among hospitalized children with sickle cell disease. Pediatr Blood Cancer (2013) 0.78
Nausea and vomiting perspectives among children receiving moderate to highly emetogenic chemotherapy treatment. Cancer Nurs (2012) 0.78
Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complications. Am J Hematol (2009) 0.77
Review of chronic graft-versus-host disease in children after allogeneic stem cell transplantation: nursing perspective. J Pediatr Oncol Nurs (2010) 0.76
Integration of Administrative Data and Chart Review for Reporting Health Care Utilization Among Children With Sickle Cell Disease. Sage Open (2013) 0.76
Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients. J Pediatr Hematol Oncol (2015) 0.76
The ASH Choosing Wisely®campaign: five hematologic tests and treatments to question. Hematology Am Soc Hematol Educ Program (2013) 0.76
Long-term use of hydroxyurea for sickle cell anemia. JAMA (2003) 0.75
Parental information, motivation, and adherence behaviors among children with sickle cell disease. Pediatr Blood Cancer (2013) 0.75
Lipid profiles of pediatric hematopoietic stem cell transplant survivors. J Pediatr Oncol Nurs (2012) 0.75
Quality improvement and evidence-based practice change projects and the institutional review board: is approval necessary? Worldviews Evid Based Nurs (2014) 0.75
Children's coping strategies for chemotherapy-induced nausea and vomiting. Oncol Nurs Forum (2012) 0.75
Creating a Pediatric Joint Council to Promote Patient Safety and Quality, Governance, and Accountability Across Johns Hopkins Medicine. Jt Comm J Qual Patient Saf (2017) 0.75
The second century of sickle cell disease. Pediatr Blood Cancer (2012) 0.75
Patient/Family Education as Translational Science in Pediatric Oncology. J Pediatr Oncol Nurs (2016) 0.75
Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. J Support Oncol (2005) 0.75